BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22753726)

  • 1. Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3.
    O'Brien A; Barber JE; Reid S; Niknejad N; Dimitroulakos J
    Anticancer Res; 2012 Jul; 32(7):2679-88. PubMed ID: 22753726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
    Niknejad N; Gorn-Hondermann I; Ma L; Zahr S; Johnson-Obeseki S; Corsten M; Dimitroulakos J
    Int J Cancer; 2014 Jan; 134(2):268-79. PubMed ID: 23824972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells.
    Bar J; Hasim MS; Baghai T; Niknejad N; Perkins TJ; Stewart DJ; Sekhon HS; Villeneuve PJ; Dimitroulakos J
    Neoplasia; 2016 Sep; 18(9):525-35. PubMed ID: 27659012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
    Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
    Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene.
    Bottone FG; Moon Y; Alston-Mills B; Eling TE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):668-77. PubMed ID: 16079301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines.
    Tanabe M; Izumi H; Ise T; Higuchi S; Yamori T; Yasumoto K; Kohno K
    Cancer Res; 2003 Dec; 63(24):8592-5. PubMed ID: 14695168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer.
    Pelzer AE; Bektic J; Haag P; Berger AP; Pycha A; Schäfer G; Rogatsch H; Horninger W; Bartsch G; Klocker H
    J Urol; 2006 Apr; 175(4):1517-22. PubMed ID: 16516039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.
    St Germain C; Niknejad N; Ma L; Garbuio K; Hai T; Dimitroulakos J
    Neoplasia; 2010 Jul; 12(7):527-38. PubMed ID: 20651982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells.
    Ko JC; Tsai MS; Chiu YF; Weng SH; Kuo YH; Lin YW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):184-94. PubMed ID: 21444628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic effect of toremifene and cisplatin on human lung cancer cell line A549].
    Zhang X; Li Q; Han Y; Liu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):537-9. PubMed ID: 12667319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.
    Bandyopadhyay S; Wang Y; Zhan R; Pai SK; Watabe M; Iiizumi M; Furuta E; Mohinta S; Liu W; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Hai T; Watabe K
    Cancer Res; 2006 Dec; 66(24):11983-90. PubMed ID: 17178897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells.
    Du A; Jiang Y; Fan C
    Int J Med Sci; 2018; 15(13):1502-1507. PubMed ID: 30443171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].
    Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
    Weng SH; Tseng SC; Huang YC; Chen HJ; Lin YW
    Biochem Pharmacol; 2012 Jul; 84(1):126-36. PubMed ID: 22480737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
    Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
    Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AdipoR2 is transcriptionally regulated by ER stress-inducible ATF3 in HepG2 human hepatocyte cells.
    Koh IU; Lim JH; Joe MK; Kim WH; Jung MH; Yoon JB; Song J
    FEBS J; 2010 May; 277(10):2304-17. PubMed ID: 20423458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram potentiates the anticancer effect of cisplatin in atypical teratoid/rhabdoid tumors (AT/RT).
    Jangra A; Choi SA; Yang J; Koh EJ; Phi JH; Lee JY; Wang KC; Kim SK
    Cancer Lett; 2020 Aug; 486():38-45. PubMed ID: 32428661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.